Sign in Subscribe

Investor Briefings

For funding rounds, due diligence insights, platform evaluations, buy/build strategy, PE insights

Investors Bet on DRBI: Positive Development’s $51.5M Raise and the Tech Behind It

Investors Bet on DRBI: Positive Development’s $51.5M Raise and the Tech Behind It

“The disruptive potential of DRBI isn’t just clinical — it’s in the tech stack required to deliver it at scale.” Context: Why Payors Care About DRBI For years, ABA has been the default therapy for autism. But as Medicaid directors and managed care executives keep reminding us, ABA is

CentralReach’s Double Play: SpectrumAi and AI.Measures Opening the Door to Outcomes-Based ABA at Scale?

CentralReach’s Double Play: SpectrumAi and AI.Measures Opening the Door to Outcomes-Based ABA at Scale?

CentralReach has announced the acquisitions of SpectrumAi and AI.Measures, signaling a strategic overhaul of its Care360 platform to lead the adoption of outcomes-based care (OBC) in autism and IDD services. With many in the ABA space talking about outcomes, CentralReach is now positioning to build the infrastructure. These acquisitions

Building the Future of ABA Tech WITH the People We Serve

Building the Future of ABA Tech WITH the People We Serve

How neurodiverse technologists could help solve ABA’s biggest data and infrastructure problems—if investors, providers, and platforms choose to lead At the University of Pittsburgh, a team of QA engineers from CAI Neurodiverse Solutions recently helped automate testing for the school’s CRM systems. Their results were remarkable: 83%

The Private Equity Dilemma in ABA

The Private Equity Dilemma in ABA

A few years ago, a wave of small and mid-sized private equity firms aggressively acquired ABA providers. Fueled by hopes of rapid scaling and a quick flip, these investors expected solid exits within 3–5 years. For many, that timeline has come and gone — and now, they face a dilemma.

ABA M&A won't pick up this year

ABA M&A won't pick up this year

Here’s my wager: We won’t see meaningful acceleration in ABA provider M&A activity this year. And I hope I’m wrong. Why? Because if I do lose this bet, it could be a sign that the ABA industry is maturing—operating models aligning, payor variability stabilizing,

Passage Health Raises $8M to Advance Its Position in ABA Tech

Passage Health Raises $8M to Advance Its Position in ABA Tech

A thoughtful platform play with potential long-term impact The ABA technology market is crowded. With a surge of investment and innovation in recent years, it’s become harder to distinguish which platforms are meaningfully solving problems for providers — and which are just adding noise. That’s why Telescope’s $8

Brellium’s Big Bet on Clinical Compliance—And Why It Matters for ABA

Brellium’s Big Bet on Clinical Compliance—And Why It Matters for ABA

Most startup funding announcements sound alike—big numbers, bold promises, broad markets. But Brellium’s recent $16.7M Series A, led by First Round Capital, is something different. They’re not chasing the latest hype cycle. They’re going after a deeply unsexy, high-stakes problem that affects every healthcare provider